NCT01950403View on ClinicalTrials.gov

Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 28, 2016

Study Completion Date

February 22, 2018

Conditions

Colorectal CancerHealthy, no Evidence of Disease

Interventions

DRUG

linaclotide acetate

Given PO

OTHER

placebo

Given PO

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER